Home › Hypopharyngeal Cancer › Nebraska › Omaha
Hypopharyngeal Cancer clinical trials in Omaha, NE
4 studies for Hypopharyngeal Cancer are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9 mi away
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RecruitingPhase 2
- Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
- Nebraska Methodist Hospital, Omaha
- Alegent Health Immanuel Medical Center, Omaha
- and 5 more
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecruitingPhase 1/2
- Nebraska Cancer Specialists, Omaha
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Methodist Estabrook Cancer Center, Omaha
- Nebraska Methodist Health System, Omaha
- University of Nebraska Medical Center, Omaha
- and 1 more
Hypopharyngeal Cancer trials in other cities
- Atlanta, GA6 studies
- Chicago, IL6 studies
- Richmond, VA5 studies
- Kansas City, MO5 studies
- Joliet, IL5 studies
- Peoria, IL5 studies
- Bloomington, IL5 studies
- Wausau, WI5 studies
- Stevens Point, WI5 studies
- Cape Girardeau, MO5 studies
- Milwaukee, WI5 studies
- Baltimore, MD4 studies
Other studies in Omaha
- Prostate Cancer27 studies
- Non-Small Cell Lung Cancer24 studies
- Breast Cancer22 studies
- Cancer (all types)18 studies
- Colorectal Cancer18 studies
- Multiple Myeloma16 studies
- Ovarian Cancer14 studies
- Non-Hodgkin Lymphoma14 studies
- Pancreatic Cancer14 studies
- Metastatic Cancer13 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Heart Failure13 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.